<DOC>
	<DOC>NCT00515684</DOC>
	<brief_summary>The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.</brief_summary>
	<brief_title>Corneal Thinning During Topical Bevacizumab Therapy</brief_title>
	<detailed_description />
	<mesh_term>Neovascularization, Pathologic</mesh_term>
	<mesh_term>Corneal Neovascularization</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>clinical diagnosis of corneal neovascularization must be able to apply eyedrop have active keratitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>